Project The use of computational methods to design drugs – Human Brain Project Specific Grant Agreement 1 Jean-Pierre Changeux
Project Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis (HERCULES) Benno Schwikowski
Project Protein synthesis machinery of Trypanosomatid as a therapeutic target Nadia Izadi-Pruneyre • Sylvie Pochet
Project Studying vulnerability to drug addiction: contribution of the nicotinic acetylcholine receptor α5 subunit. Morgane Besson
Project Toxins and VHHs as subtype-specific ligands and allosteric modulators of nicotinic acetylcholine receptors (PTR Nicobinder) Pierre-Jean Corringer
Project Discovery of allosteric modulators specifically targeting α5-containing nAChRs. (ANR-Nicofive) Pierre-Jean Corringer
Project Mutations in PDZ Binding Motif (PBM)-containing proteins associated to the Usher syndrome Nicolas Wolff
Project DIM ELICIT – Domain of Main Interest “Empowering LIfe sCiences with Innovative Technologies” Jean-Christophe Olivo-Marin • Elodie Brient-Litzler • Patrick Tabeling
Project GATTACA: Genetics of Alternative TranscripT Abundance upon Cellular Activation Maxime Rotival
Project ERC starting grant – CRISPAIR: Study of the interplay between CRISPR interference and DNA repair pathways towards the development of novel CRISPR tools David Bikard
Project Conformational sampling and functional dynamics of histidine kinases Nathalie Duclert-Savatier • Thérèse Malliavin
Project Development of inhibitors targeting the allosteric activation of adenyl cyclases Thérèse Malliavin
Project Targeting biomechanical properties of infected red blood cells to block malaria parasite transmission
Project Set-up a humanized mouse model for testing new Plasmodium falciparum transmission-blocking drugs
Project ATIP-Avenir: Unravelling the role of erythrocyte deformability in Plasmodium falciparum transmission
Project Des souris et des hommes : séjour d’observation à l’hôpital pour scientifiques Clementine Schilte